相关实验视频
Updated: Jun 22, 2026

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
20.8K
设计先进的药物输送系统:通过电流动性原子化进行核心外的酸盐颗粒
Iriczalli Cruz-Maya1, Carmine Schiavone2,3, Rosalia Ferraro2,4
1Institute for Polymers, Composites and Biomaterials, National Research Council, 80125 Naples, Italy.
Pharmaceutics
|February 24, 2024
概括
这项研究引入了电流动动性原子化 (EFDA) 来创建核心外单相粒子 (CSMp) 用于先进的药物输送. 优化的颗粒特性允许精确控制药物释放特征,提高治疗效率.
科学领域:
- 材料科学 材料科学 材料科学
- 制药技术 制药技术 制药技术
- 生物医学工程 生物医学工程
背景情况:
- 药物输送系统需要创新以改善治疗结果.
- 电流动动性原子化 (EFDA) 为先进的粒子结构提供了一种新的制造方法.
研究的目的:
- 为了制造核心外单相粒子 (CSMp),使用基酸盐的EFDA.
- 研究材料特性和工艺条件对CSMp形态学的影响.
- 开发一个预测模型来模拟这些颗粒的药物释放动力学.
主要方法:
- 使用电流动动性原子化 (EFDA) 制造CSMp.
- 粒子形态的表征和与材料性质的关系.
- 使用运输和学模型开发用于释放动力学模拟的数学模型.
- 评估小分子 (二二) 和凝配方的扩散特性.
主要成果:
- 成功制造具有可调整形态特征的CSMp.
- 确定外厚度和扩散率作为药物释放控制的关键独立参数.
- 开发一种用于评估药物递送效率的预测模型.
结论:
- EFDA是一种可行的技术,用于制造具有药物输送潜力的CSMp.
- 通过操纵颗粒特征,可以精确控制药物释放概况.
- 这项研究为开发具有定制释放动力学的增强药物递送系统提供了一条途径.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...

